Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave

被引:0
|
作者
Jessica T. Davis
Matteo Chinazzi
Nicola Perra
Kunpeng Mu
Ana Pastore y Piontti
Marco Ajelli
Natalie E. Dean
Corrado Gioannini
Maria Litvinova
Stefano Merler
Luca Rossi
Kaiyuan Sun
Xinyue Xiong
Ira M. Longini
M. Elizabeth Halloran
Cécile Viboud
Alessandro Vespignani
机构
[1] Northeastern University,Laboratory for the Modeling of Biological and Socio
[2] University of Greenwich,technical Systems
[3] Indiana University School of Public Health,Networks and Urban Systems Centre
[4] Emory University,Department of Epidemiology and Biostatistics
[5] ISI Foundation,Department of Biostatistics and Bioinformatics
[6] Bruno Kessler Foundation,Division of International Epidemiology and Population Studies, Fogarty International Center
[7] National Institutes of Health,Department of Biostatistics, College of Public Health and Health Professions
[8] University of Florida,Department of Biostatistics
[9] Vaccine and Infectious Disease Division,undefined
[10] Fred Hutchinson Cancer Research Center,undefined
[11] University of Washington,undefined
来源
Nature | 2021年 / 600卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Considerable uncertainty surrounds the timeline of introductions and onsets of local transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) globally1–7. Although a limited number of SARS-CoV-2 introductions were reported in January and February 2020 (refs.8,9), the narrowness of the initial testing criteria, combined with a slow growth in testing capacity and porous travel screening10, left many countries vulnerable to unmitigated, cryptic transmission. Here we use a global metapopulation epidemic model to provide a mechanistic understanding of the early dispersal of infections and the temporal windows of the introduction of SARS-CoV-2 and onset of local transmission in Europe and the USA. We find that community transmission of SARS-CoV-2 was likely to have been present in several areas of Europe and the USA by January 2020, and estimate that by early March, only 1 to 4 in 100 SARS-CoV-2 infections were detected by surveillance systems. The modelling results highlight international travel as the key driver of the introduction of SARS-CoV-2, with possible introductions and transmission events as early as December 2019 to January 2020. We find a heterogeneous geographic distribution of cumulative infection attack rates by 4 July 2020, ranging from 0.78% to 15.2% across US states and 0.19% to 13.2% in European countries. Our approach complements phylogenetic analyses and other surveillance approaches and provides insights that can be used to design innovative, model-driven surveillance systems that guide enhanced testing and response strategies.
引用
收藏
页码:127 / 132
页数:5
相关论文
共 50 条
  • [1] Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave
    Davis, Jessica T.
    Chinazzi, Matteo
    Perra, Nicola
    Mu, Kunpeng
    Piontti, Ana
    Ajelli, Marco
    Dean, Natalie E.
    Gioannini, Corrado
    Litvinova, Maria
    Merler, Stefano
    Rossi, Luca
    Sun, Kaiyuan
    Xiong, Xinyue
    Longini, Ira M., Jr.
    Halloran, M. Elizabeth
    Viboud, Cecile
    Vespignani, Alessandro
    NATURE, 2021, 600 (7887) : 127 - +
  • [2] COVID-19 vaccines and decreased transmission of SARS-CoV-2
    Vitiello, A.
    Ferrara, F.
    Troiano, V
    La Porta, R.
    INFLAMMOPHARMACOLOGY, 2021, 29 (05) : 1357 - 1360
  • [3] Intrauterine Transmission of SARS-CoV-2 (COVID-19 Virus)
    Mukta agarwal
    Swmkwr basumatary
    Bhavesh kant
    Sanjeev kumar
    The Journal of Obstetrics and Gynecology of India, 2021, 71 : 349 - 351
  • [4] Intrauterine Transmission of SARS-CoV-2 (COVID-19 Virus)
    Agarwal, Mukta
    Basumatary, Swmkwr
    Kant, Bhavesh
    Kumar, Sanjeev
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2021, 71 (03): : 349 - 351
  • [5] COVID-19 vaccines and decreased transmission of SARS-CoV-2
    A. Vitiello
    F. Ferrara
    V. Troiano
    R. La Porta
    Inflammopharmacology, 2021, 29 : 1357 - 1360
  • [6] Airborne transmission of SARS-CoV-2 disease (COVID-19)
    Parvez, Mohammad K.
    Parveen, Shama
    FUTURE VIROLOGY, 2022, 17 (05) : 261 - 264
  • [7] SARS-CoV-2 and COVID-19
    Sheng, Wang-Huei
    Ko, Wen-Chien
    Huang, Yhu-Chering
    Hsueh, Po-Ren
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2020, 53 (03) : 363 - 364
  • [8] SARS-CoV-2 transmission via endoscopy in the COVID-19 era
    不详
    GUT, 2021, 70 (11) : 2218 - 2219
  • [9] Covid-19 Intra-family transmission of Sars-CoV-2
    Gauzere, Bernard-Alex
    ACTUALITES PHARMACEUTIQUES, 2020, 59 (601): : 4 - 4
  • [10] The role of environmental factors to transmission of SARS-CoV-2 (COVID-19)
    Eslami, Hadi
    Jalili, Mahrokh
    AMB EXPRESS, 2020, 10 (01)